AI assistant
Sending…
Vanda Pharmaceuticals Inc. — Director's Dealing 2009
Aug 31, 2009
33390_dirs_2009-08-31_a24b94a0-0e66-4433-ac48-6f8485ccfdf1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2009-08-27
Reporting Person: KARABELAS ARGERIS N (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-08-27 | Nonstatutory Stock Option (Right to Buy) | $14.78 | A | 15000 | Acquired | 2019-08-26 | Common Stock (15000) | Direct |
Footnotes
F1: The option vests in 12 equal monthly installments beginning on September 27, 2009.
More from Vanda Pharmaceuticals Inc.
Regulatory Filings
2026
Jun 5
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Board/Management Information
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 19